Qure.ai — which is headquartered in India — closed a $65 million Series D financing round. When asked whether the startup is thinking about a public exit anytime soon, CEO Prashant Warie said that for now, the company’s focusing is on continuing to build its market globally and “venturing deeper into meeting the healthcare challenges…
By MIKE MAGEE Give thanks for our America, blemishes and all. Ken Burns says as much, making it clear, we are a mess of contradictions, and that is (in part) what makes us a uniquely American. Consider that in a single week, we have had to endure Trump’s “Things happen” as he defended the Saudi…
This fact sheet explains the types of permanent contraception or sterilization procedures available, reviews private insurance and Medicaid coverage policy, and discusses issues that affect availability in the U.S.
It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable. The post Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis appeared first on MedCity News.
FamilyWell’s financing was led by New Markets Venture Partners and included participation from .406 Ventures, GreyMatter Capital, The Alix Foundation, The Donna Fund and The Lee Foundation. The post FamilyWell Health Lands $8M to Grow Women’s Mental Health Support appeared first on MedCity News.
Higher market concentration in Medicare Advantage insurance markets may lower the incentive for insurers to compete for potential enrollees by making plans more appealing through more comprehensive benefits or lower costs.
In this episode, we’re joined by Claire Love, PwC’s global health industries advisory leader. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market. The post MedCity FemFwd: Opportunities in the Fertility Market appeared first on MedCity News.
MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed whether bitcoin would play a greater role in healthcare deals and the Trump administration’s mixed messages on autism and Tylenol. The post Debunked Episode 20: A Look at H-1B Visas in Healthcare, M&A Deals for Bitcoin and…
Vertex Pharmaceuticals’ Jounavx is now FDA approved, providing patients a non-opioid option for treating acute pain. The twice-daily pill is the first in a new class of medicines that block a key pathway in the peripheral nervous system. The post Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds…